Wee-Shian Chan

Dr. Wee-Shian Chan


Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2000 in Archives of internal medicine (1960)
Verified
Journal Article
Open access
PDF file
WCWee-Shian Chan
Wee-Shian Chan
SASonia Anand
Sonia Anand
JGJeffrey S. Ginsberg
Jeffrey S. Ginsberg
Research from JAMA Internal Medicine — Anticoagulation of Pregnant Women With Mechanical Heart Valves — A Systematic Review of the Literature

1 August 2001 in QJM: An International Journal of Medicine
Verified
Journal Article
Open access
PDF file
JRJ.G. Ray
J.G. Ray
TOT.E. O'Brien
T.E. O'Brien
WCWee-Shian Chan
Wee-Shian Chan
Offspring of women with pregestational diabetes mellitus are at increased risk for congenital malformations, largely attributable to poor periconceptional glycaemic control. We assessed the effect of preconception care in reducing congenital malformations, in a meta‐analysis of published studies of preconception care in women with diabetes mellitus. Articles were retrieved from Medline (1970 to June 2000) and Embase (1980 to June 2000), and data abstracted by two independent reviewers. The rates and relative risks (RR) for major and minor congenital malformations were pooled from all eligible studies using a random effects model, as were early first‐trimester glycosylated haemoglobin values. In 14 cohort studies, major congenital malformations were assessed among 1192 offspring of mothers who had received preconception care, and 1459 offspring of women who had not. The pooled rate of major anomalies was lower among preconception care recipients (2.1%) than non‐recipients (6.5%) (RR 0.36, 95%CI 0.22–0.59). In nine studies, the risk for major and minor anomalies was also lower among women who received preconception care (RR 0.32, 95%CI 0.17–0.59), as were the early first‐trimester mean glycosylated haemoglobin values (pooled mean difference: 2.3%, 95%CI 2.1–2.4). Women who received preconception care were, on average, 1.8 years older than non‐recipients, and fewer smoked (19.6% vs. 30.2%). Only one study described the routine use of periconception folic acid. Out‐patient preconception care probably reduces the risk of major congenital anomalies among the offspring of women with pregestational diabetes mellitus. Because many women with diabetes neither plan their pregnancy nor achieve adequate glycaemic control before conception, strategies are needed to improve access to these programs, and to maximize those interventions associated with improved pregnancy outcome, such as smoking cessation and folic acid use.

1 June 2014 in Journal of Obstetrics and Gynaecology Canada
Verified
Journal Article
Closed access
WCWee-Shian Chan
Wee-Shian Chan
EREvelyne Rey
Evelyne Rey
NKNancy E. Kent
Nancy E. Kent
TCThomas Corbett
Thomas Corbett
MDMichèle David
Michèle David
RSReginald E. Smith
Reginald E. Smith

1 April 1999 in Obstetrical & Gynecological Survey
Verified
Journal Article
Closed access
JRJ. G. Ray
J. G. Ray
WCWee-Shian Chan
Wee-Shian Chan
We performed a meta-analysis of all published studies of deep vein thrombosis during pregnancy and the puerperium using MEDLINE between 1966 and May 1998. Data were pooled using a random effects model. Fourteen studies included relevant information on deep vein thrombosis in pregnancy or the puerperium, and used objective testing to diagnose deep vein thrombosis. The pooled event rate for left sided or bilateral deep vein thrombosis was 82.2 percent (95 percent CI 75.1 to 87.5). There was no statistical evidence of heterogeneity for this figure (P = .08). Twelve studies reported on the trimester in which deep vein thrombosis was diagnosed. The deep vein thrombosis event rate during the first trimester was 21.9 percent (95 percent CI 17.4 to 27.3), 33.7 percent (95 percent CI 28.1 to 39.8) during the second trimester, and 47.6 percent (95 percent CI 39.2 to 56.2) for the third trimester. Heterogeneity testing was not significant. Nine studies compared deep vein thrombosis events between the antepartum and puerperium periods, with 65.5 percent (95 percent CI 58.1 to 72.1) arising during pregnancy, and 34.5 percent (95 percent CI 27.9 to 41.9) postpartum (P = .08, not heterogeneous). Using these figures, the estimated relative distribution of 100 deep vein thrombosis events during pregnancy and the puerperium would be 0.23 per day during pregnancy, and 0.82 per day in the postpartum period. During pregnancy and the puerperium, deep vein thrombosis is more likely to arise in the left leg. More than half of all deep vein thromboses during pregnancy occur during the first and second trimesters. Furthermore, during the puerperium, the risk of developing deep vein thrombosis is significantly higher than antepartum. Obstetricians & Gynecologists, Family Physicians. After completion of this article, the reader will be able to understand the incidence and distribution of DVTs during pregnancy and to be able to appreciate the differing risk of DVT during the various time periods in a pregnancy.

1 November 2014 in The Lancet
Verified
Journal Article
Closed access
MRMarc A Rodger
Marc A Rodger
WHWilliam M Hague
William M Hague
JKJohn Kingdom
John Kingdom
SKSusan R Kahn
Susan R Kahn
AKAlan Karovitch
Alan Karovitch
PWPhilip S Wells
Philip S Wells

14 November 2017 in JAMA
Verified
Journal Article
Open access
PDF file
SLSarka Lisonkova
Sarka Lisonkova
GMGiulia M. Muraca
Giulia M. Muraca
JPJayson Potts
Jayson Potts
JLJessica Liauw
Jessica Liauw
WCWee-Shian Chan
Wee-Shian Chan
KLKenneth I. Lim
Kenneth I. Lim
Quiz Ref ID The age-adjusted prevalence of obesity among US women increased from 15.8% in 1960 to 40.4% in 2014.1,2 In 2014, half of pregnant women were either overweight (25.6%) or obese (24.8%).3 Overweight and obesity are associated with elevated risks of preterm birth, large-for-gestational-age live birth, macrosomia, shoulder dystocia, congenital anomalies, birth injury, stillbirth, cerebral palsy, and neonatal and infant death,4-11 while underweight is associated with preterm birth, small-for-gestational-age birth, and neonatal intensive care unit admission.11 Less is known about the association between body mass index (BMI) and potentially life-threatening maternal morbidity. Some studies have shown an association between obesity and pregnancy complications including hypertension in pregnancy and preeclampsia, gestational diabetes, thromboembolism, and cesarean delivery,4,11-15 although 1 study suggested that the overall risk of severe maternal morbidity does not increase with BMI.11